Drug Type Small molecule drug |
Synonyms AG 1350, LY 316340, LY 316957 + [3] |
Target |
Action inhibitors |
Mechanism HIV-1 protease inhibitors(Human immunodeficiency virus type 1 protease inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC31H45N3O7S3 |
InChIKeyWYCLUAUPFCMDTI-KZMNDDLNSA-N |
CAS Registry169104-93-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HIV Infections | Preclinical | United States | 01 Dec 1995 |





